Pelthos Therapeutics Inc. (PTHS)
Automate Your Wheel Strategy on PTHS
With Tiblio's Option Bot, you can configure your own wheel strategy including PTHS - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol PTHS
- Rev/Share 2.4191
- Book/Share 19.0277
- PB 1.3906
- Debt/Equity 0.0597
- CurrentRatio 1.9804
- ROIC -0.2133
- MktCap 17159336.0
- FreeCF/Share -5.5556
- PFCF -1.0089
- PE -3.4352
- Debt/Assets 0.0275
- DivYield 0
- ROE -2.1032
- Rating C
- Score 2
- Recommendation Sell
- P/E Score 1
- DCF Score 1
- P/B Score 3
- D/E Score 3
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Initiation | PTHS | Roth Capital | -- | Buy | -- | $57 | Nov. 25, 2025 |
| Initiation | PTHS | Oppenheimer | -- | Outperform | -- | $50 | Sept. 2, 2025 |
News
Pelthos Therapeutics Inc. (PTHS) Q3 2025 Earnings Call Transcript
Published: November 13, 2025 by: Seeking Alpha
Sentiment: Neutral
Pelthos Therapeutics Inc. ( PTHS ) Q3 2025 Earnings Call November 13, 2025 8:00 AM EST Company Participants Mike Moyer Scott Plesha - CEO, President & Director Sai Rangarao Francis Knuettel - Chief Financial Officer Conference Call Participants Jeffrey Jones - Oppenheimer & Co. Inc., Research Division James Molloy - Alliance Global Partners, Research Division Presentation Operator Greetings, and welcome to the Pelthos Therapeutics Third Quarter 2025 Financial Results Conference Call. [Operator Instructions] Please note, this conference is being recorded.
Read More
About Pelthos Therapeutics Inc. (PTHS)
- IPO Date 2025-07-02
- Website https://pelthos.com
- Industry Biotechnology
- CEO Scott Plesha
- Employees 4